Quarterly report pursuant to Section 13 or 15(d)

Share-based Payments - Summary of Stock Options Activity (Details)

v3.19.1
Share-based Payments - Summary of Stock Options Activity (Details)
3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Shares, Beginning Balance | shares 10,502
Number of Shares, Granted | shares
Number of Shares, Exercised | shares
Number of Shares, Forfeited | shares (3,625)
Number of Shares, Cancelled/Expired | shares
Number of Shares, Ending Balance | shares 6,877
Number of Shares, Exercisable | shares 6,877
Weighted Average Exercise Price, Beginning Balance $ 30.41
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited 29.02
Weighted Average Exercise Price, Cancelled/Expired
Weighted Average Exercise Price, Ending Balance 31.14
Weighted Average Exercise Price, Exercisable 31.14
Weighted Average Grant Date Fair Value, Beginning 17.42
Weighted Average Grant Date Fair Value, Granted
Weighted Average Grant Date Fair Value, Exercised
Weighted Average Grant Date Fair Value, Forfeited 22.40
Weighted Average Grant Date Fair Value, Cancelled/Expired
Weighted Average Grant Date Fair Value, Ending 14.80
Weighted Average Grant Date Fair Value, Exercisable $ 14.80
Weighted Average Remaining Contractual Term (Years), Beginning 1 year 5 months 5 days
Weighted Average Remaining Contractual Term (Years), Granted 0 years
Weighted Average Remaining Contractual Term (Years), Exercised 0 years
Weighted Average Remaining Contractual Term (Years), Forfeited 0 years
Weighted Average Remaining Contractual Term (Years), Cancelled/Expired 0 years
Weighted Average Remaining Contractual Term (Years), Ending 1 year 1 month 20 days
Weighted Average Remaining Contractual Term (Years), Exercisable 1 year 1 month 20 days
Aggregate Intrinsic Value, Beginning Balance | $
Aggregate Intrinsic Value, Ending Balance | $
Aggregate Intrinsic Value, Exercisable | $